Ocugen (OCGN) Exchange Rate Effect (2018 - 2026)
Ocugen (OCGN) posted Exchange Rate Effect of $102000.0 for Q1 2026, up 3300.0% on a QoQ basis from $3000.0 in Q4 2025, and up 1375.0% year-over-year from $6915.3 in Q1 2025.
Ocugen (OCGN) Exchange Rate Effect (2018 - 2026) Analysis & Trends
Ocugen's Exchange Rate Effect history runs 7 years deep, the most recent figure standing at $102000.0 for Q1 2026.
- Quarterly Exchange Rate Effect rose 1375.0% year-over-year to $102000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $123000.0 (up 720.0% YoY) and the FY2025 annual result came in at $13000.0, down 53.57% from the prior year.
- Exchange Rate Effect was $102000.0 for Q1 2026 at Ocugen, up from $3000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $102000.0 in Q1 2026 and bottomed at -$28000.0 in Q2 2025.
- A 5-year average of $10187.5 and a median of $3000.0 in 2024 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2025 — Exchange Rate Effect sank 1033.33% — and 2026, when it surged 1375.0%.
- Ocugen's Exchange Rate Effect stood at -$5000.0 in 2022, then tumbled by 40.0% to -$7000.0 in 2023, then surged by 457.14% to $25000.0 in 2024, then sank by 88.0% to $3000.0 in 2025, then surged by 3300.0% to $102000.0 in 2026.
- Business Quant data shows OCGN's Exchange Rate Effect at $102000.0 in Q1 2026, $3000.0 in Q4 2025, and $46000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - | 102,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102,000.00 |
| Mar 31, 2026 | 102,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 46,000.00 |
| Sep 30, 2025 | 46,000.00 |
| Jun 30, 2025 | -28,000.00 |
| Jun 30, 2025 | -28,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Dec 31, 2023 | -7,000.00 |